Külli Kingo

Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

Eric L. Simpson, Thomas Bieber, Emma Guttman‐Yassky et al. · New England Journal of Medicine · 2016 · 2K citations · Full text

Medicine, Dermatology, Immunology +12

Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial

Diamant Thaçi, Andrew Blauvelt, Kristian Reich et al. · Journal of the American Academy of Dermatology · 2015 · 541 citations · Full text

Medicine, Dermatology, Pharmacotherapy +14

Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE)

Andrew Blauvelt, Jörg C. Prinz, Alice B. Gottlieb et al. · British Journal of Dermatology · 2014 · 320 citations

Medicine, Dermatology, Pharmacology +17

Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study

Andrew Blauvelt, Kristian Reich, Tsen‐Fang Tsai et al. · Journal of the American Academy of Dermatology · 2016 · 304 citations

Medicine, Dermatology, Immunology +14

Clinical and genetic differences between pustular psoriasis subtypes

Sophie Twelves, Alshimaa Mostafa, Nick Dand et al. · Journal of Allergy and Clinical Immunology · 2018 · 268 citations · Full text

Life Sciences, Dermatology, Genetics +15